Probiotics in the treatment of atopic dermatitis in children. Clinical experience
https://doi.org/10.21518/2079-701X-2020-1-145-150
Abstract
Relevance. The article is devoted to a topical problem - treatment and prevention of atopic dermatitis in children, which occurs most often in the practice of pediatricians and dermatologists, taking leading positions among the diseases of childhood. The prevalence of atopic dermatitis among children’s population is about 20%. To treat atopic dermatitis, along with diet and drug therapy, the possibility of using probiotics is being discussed. Literary analysis and practical experience show the significant role of probiotics in the prevention and treatment of atopic dermatitis patients. Due to the unfavourable environmental situation, changing nutrition patterns and increasing percentage of children on complementary feeding, there is a steady increase in allergic diseases in children worldwide. Aim. The aim of the study was to justify the efficacy and safety of probiotics for the recovery of intestinal microbiocenosis in integrated therapy and prevention of atopic dermatitis in children.
Materials and methods. As materials of the study the review of the literature sources and clinical cases of complex treatment of atopic dermatitis with addition of probiotics Linex baby® to the basic therapy are presented. Clinical manifestations of the disease were assessed. Addition of probiotic Linex baby® contributed to a marked decrease in the typical clinical manifestations of the disease, the intensity of itching, and the resolution of rashes in a shorter period of time compared to patients in whom no probiotics were used.
Conclusions. Thus, the addition of probiotic Linex baby® to the basic therapy of atopic dermatitis contributed to a shortening of the period of exacerbation of the disease and marked improvement of the clinical picture of the disease, which confirms the prospects and feasibility of probiotic drugs in the treatment of this disease.
About the Authors
N. V. Nekrasova
Centre for Specialized Types of Medical Care of the Kaliningrad Region
Russian Federation
Russian Federation
Natal’ya V. Nekrasova - Honoured Doctor of the Russian Federation, Deputy Chief Medical Officer, Dermatovenerologist of the highest category, Chief Specialist of the Ministry of Health of the Kaliningrad Region for Dermatovenerology and Cosmetology.
6, Barnaulskaya St., Kaliningrad, 236006E. R. Spirkina
Centre for Specialized Types of Medical Care of the Kaliningrad Region
Russian Federation
Russian Federation
Elizaveta R. Spirkina – dermatovenerologist.
6, Barnaulskaya St., Kaliningrad, 236006P. V. Nekrasova
Wroclaw Medical University
Poland
Poland
Polina V. Nekrasova - 5th year student of the Faculty of Medicine.
Wybrzeze L. Pasteura 1, 50-367 WroclawReferences
1. Kubanov A.A. Statistical materiaLs of SBPHI CSTMC. In: XIX Congress on dermatology and cosmetology. Moscow, June 18-21, Moscow; 2019.
2. GorLanov I.A., ZasLavskiy D.V., MiLyavskaya I.R., Leina L.M., OLovyanishnikov O.V., KuLikova S.Yu. Detskaya dermatovenerologiya = Pediatric der-matovenerology. Moscow: Academy; 2012. (In sensitization and airway inflammation is associated with increase of T reguLatory-dependent mechanisms in a murine modeL of asthma. Clin Exp Allergy. 2007;37(4):498-505. doi:10.1111/j.1365-2222.2006.02629.x.
3. Zaharova I.N., Dmitrieva Yu.A. Features of formation of intestinaL microflora in infants. Pediatria. 2014;93(6):138-144. (In Russ.) AvaiLabLe at: https://pediatriajournaL.ru/fiLes/upLoad/mags/343/2014_6_4158.pdf.
4. Eisenbarth S.C., Piggott D.A., HuLeatt J.W. et aL. LipopoLysaccharide-enhanced, toLL-Like receptor 4-dependent T heLper ceLL type 2 responses to inhaLed antigen. J Exp Med. 2002;196(12):1645-1651. doi:10.1084/jem.20021340.
5. Kornienko E.A. Probiotics and food allergy. Voprosy prakticheskoy pediatrii = Clinical Practice in Pediatrics. 2016;11(4):60-64. (In Russ.) doi: 10.20953/1817-7646-2016-4-60-64.
6. Feleszko W., Jaworska J., Rha R.D. et al. Probiotic - induced suppression of alergic sensitization and airway inflammation is associated with increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy. 2007;37(4):498-505. doi:10.1111/j.1365-2222.2006.02629.x.
7. Rusu E., Enache G., Cursaru R., et aL. Prebiotics and probiotics in atopic dermatitis. Exp and Therapeutic Medicine. 2019;18(2):926-931. doi: 10.3892/etm.2019.7678.
8. Jungersen M., Wind A. et aL. The Science behind the Probiotic Strain Bifidobacterium animaLis subsp. Lactis BB-12(®). Microorganisms. 2014;(2):92-110. doi: 10.3390/microorganisms2020092.
9. Lopez P., Gueimonde M., MargoLLes A., Suarez A. Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol. 2010;138(1-2):157-165. doi: 10.1016/j.ijfood-micro.2009.12.023.
10. LatvaLa S., PietiLa T.E., Veckman V., Kekkonen R.A., Tynkkynen S., KorpeLa R., JuLkunen I. PotentiaLLy probiotic bacteria induce efficient maturation but differentiaL cytokine production in human monocyte-derived dendritic ceLLs. World J Gastroenterol. 2008;14(36):5570-5581. doi: 10.3748/wjg.14.5570. Russ.) AvaiLabLe at: http://kingmed.info/knigi/DermatoveneroLogiya/book_3753/Detskaya_dermatoveneroLogiya-GorLanov_IA_ZasLavskiy_DV_MiLyavskaya_IR_Leina_LM_OLovyannikov_OV_KuLikova_SYu-2012-pdf.
11. Matsumoto M., Hara K., Benno Y. The influence of the immunostimuLation by bacteriaL ceLL components derived from aLtered Large intestinaL microbiota on probiotic anti-infLammatory benefits. FEMS Immunol. Med. Microbiol. 2007;49(3):387-390. doi: 10.1111/j.1574-695X.2007.00215.x.
12. HoLscher H.D., Czerkies L.A., CekoLa P. et aL. Bifidobacterium Lactis Bb12 enhances intestinaL antibody response in formuLa-fed infants: a randomized, doubLe-bLind, controLLed triaL. JPEN J Parenter Enteral Nutr. 2012;36(1):106S-17S. doi: 10.1177/0148607111430817.
13. Rautava S., ArviLommi H., IsoLauri E. Specific probiotics in enhancing maturation of IgA responses in formuLa-fed infants. Pediatr Res. 2006;60(2):221-224. doi: 10.1203/01.pdr.0000228317.72933.db.
14. IsoLauri E., ArvoLa T., Suetas T., MoiLanen E., SaLminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30(11):1604-1610. doi:10.1046/j.1365-2222.2000.00943.x.
15. Kirjavainen P.V., ArvoLa T., SaLminen S.J., IsoLauri E. Aberrant composition of gut microbiota of aLLergic infants: a target of bifidobacteriaL therapy at weaning? Gut. 2002;51(1):51-55. doi: 10.1136/gut.51.1.51.
Review
For citations:
Nekrasova NV, Spirkina ER, Nekrasova PV. Probiotics in the treatment of atopic dermatitis in children. Clinical experience. Meditsinskiy sovet = Medical Council. 2020;(1):145-150. (In Russ.) https://doi.org/10.21518/2079-701X-2020-1-145-150
Views:
1270
Email this article 